| Dec'18 | Dec'17 | Dec'16 | Dec'15 | |||
|---|---|---|---|---|---|---|
Cash flows from operating activities | ||||||
Net loss | ||||||
-162,517 | -204,285 | -48,103 | -371 | |||
Adjustments to reconcile net loss | ||||||
Depreciation and amortization | ||||||
145,485 | 98,890 | 79,639 | - | |||
Fees paid in stock | ||||||
- | 23,875 | - | - | |||
HGM contract termination fee paid in stock | ||||||
- | 10,000 | - | - | |||
Original issue discount and debt issuance cost amortization | ||||||
10,913 | 12,280 | 13,684 | - | |||
Impairment of goodwill and other intangible assets | ||||||
48,127 | 69,437 | - | - | |||
Provision for doubtful accounts | ||||||
2,767 | 500 | 756 | - | |||
Deferred income tax provision | ||||||
3,352 | -66,723 | -15,729 | - | |||
Share-based compensation expense | ||||||
7,647 | 6,743 | 7,086 | - | |||
Foreign currency remeasurement | ||||||
1,180 | -1,382 | -193 | - | |||
Loss (gain) on sale of assets | ||||||
-2,095 | -399 | -2,245 | - | |||
Fair value adjustment for interest rate swap | ||||||
-2,540 | -1,297 | - | - | |||
Interest income on restricted cash and cash equivalents held in Trust Account | ||||||
- | - | - | 155 | |||
Change in operating assets and liabilities, net of effect from acquisitions | ||||||
Accounts receivable | ||||||
19,319 | 4,832 | -20,801 | - | |||
Prepaid expenses and other assets | ||||||
2,820 | -2,628 | -4,969 | - | |||
Prepaid insurance | ||||||
- | - | - | 47 | |||
Accounts payable and accrued liabilities | ||||||
5,157 | 69,551 | 9,033 | 67 | |||
Related party payables | ||||||
-6,710 | 4,907 | -2,427 | - | |||
Net cash used in operating activities | ||||||
30,457 | 23,455 | 72,147 | -508 | |||
Cash flows from investing activities | ||||||
Purchase of property, plant and equipment | ||||||
20,072 | 14,440 | 7,926 | - | |||
Additions to internally developed software | ||||||
7,438 | 7,843 | 13,017 | - | |||
Additions to outsourcing contract costs | ||||||
7,552 | 10,992 | 14,636 | - | |||
Cash acquired in Quinpario reverse merger | ||||||
- | 91 | - | - | |||
Cash paid in acquisition, net of cash received | ||||||
34,810 | 423,797 | - | - | |||
Cash acquired in TransCentra acquisition | ||||||
- | - | 3,351 | - | |||
Proceeds from sale of assets | ||||||
3,568 | 4,607 | 626 | - | |||
Proceeds deposited in trust account | ||||||
- | - | - | 350,000 | |||
Proceeds released from trust account | ||||||
- | - | - | 0 | |||
Net cash used in investing activities | ||||||
-66,304 | -452,374 | -31,602 | -349,999 | |||
Cash flows from financing activities | ||||||
Change in bank overdraft | ||||||
- | -210 | -1,331 | - | |||
Loss on extinguishment of debt | ||||||
-1,067 | -35,512 | - | - | |||
Proceeds from issuance of stock | ||||||
- | 204,417 | - | - | |||
Cash received from Quinpario | ||||||
- | 27,031 | - | - | |||
Repurchases of common stock | ||||||
7,221 | 249 | - | - | |||
Borrowings from other loans | ||||||
11,557 | 3,116 | 5,429 | - | |||
Repayment of note payable to related party | ||||||
- | - | - | -325 | |||
Proceeds from issuance of common stock to initial stockholder | ||||||
- | - | - | 0 | |||
Cash paid for equity issuance costs | ||||||
7,500 | 149 | - | 0 | |||
Contribution from Shareholders | ||||||
- | 20,548 | - | - | |||
Proceeds from senior secured term loans | ||||||
30,000 | 1,320,500 | - | - | |||
Retirement of previous credit facilities | ||||||
- | 1,055,736 | - | - | |||
Cash paid for debt issuance costs | ||||||
1,094 | 39,837 | - | - | |||
Borrowings from senior secured revolving facility | ||||||
30,000 | 72,600 | 53,700 | - | |||
Repayments on senior secured revolving facility | ||||||
30,000 | 72,500 | 53,200 | - | |||
Principal repayments on senior secured term loans and other loans | ||||||
28,719 | 39,316 | 47,853 | - | |||
Proceeds from note payable to related party | ||||||
- | - | - | 84 | |||
Proceeds from initial public offering, net of costs | ||||||
- | - | - | 342,628 | |||
Proceeds from private placement | ||||||
- | - | - | 9,000 | |||
Net cash provided by (used in) financing activities | ||||||
-1,910 | 475,727 | -43,255 | 351,388 | |||
Effect of exchange rates on cash | ||||||
122 | 429 | -2,059 | - | |||
Net decrease in cash and cash equivalents | ||||||
-37,635 | 47,237 | -4,769 | 880 | |||
Supplemental cash flow data: | ||||||
Income tax payments, net of refunds received | ||||||
7,827 | 5,711 | 3,771 | - | |||
Interest paid | ||||||
146,076 | 69,622 | 96,166 | - | |||
Noncash investing and financing activities: | ||||||
Assets acquired through right-of-use arrangements | ||||||
14,920 | 6,973 | 11,925 | - | |||
Leasehold improvements funded by lessor | ||||||
1,565 | 146 | 5,186 | - | |||
Issuance of common stock as consideration for Novitex | ||||||
- | 244,800 | - | - | |||
Accrued capital expenditures | ||||||
2,820 | 1,621 | 580 | - | |||
Dividend equivalent on Series A Preferred Stock | ||||||
0 | 16,375 | - | - | |||
Liability assumed of Quinpario | ||||||
- | 4,672 | - | - | |||
Deferred underwriters' fees | ||||||
- | - | - | 12,250 | |||
Ordinary shares subject to possible redemption related to public offering | ||||||
- | - | - | 334,157 | |||
Change in value of shares subject to redemption | ||||||
- | - | - | -363 | |||